LivingGLP1
Descriptive only

SF-36 physical component summary change

Metabolic dysfunction associated steatotic liver disease or steatohepatitis

weeks 20 to 130 (target week 52)Treatment policyEach dose separatelyMean difference
1
Randomized trials
4
Treatments
320
Participants
4
Trial arms

In plain language

No network meta-analysis was fitted here. The protocol requires at least two trials forming a connected network; this outcome has 1 trial. The trial data below are shown as reported.

Network of trials

Each circle is a treatment; each line joins treatments that were randomized against each other in at least one trial.
PLACEBOSEMA_SC_0p1MG_QDSEMA_SC_0p2MG_QDSEMA_SC_0p4MG_QD
Node area shows participants; line width shows trials comparing two treatments directly. Blue: GLP-1 receptor agonist containing treatments; grey: comparators. Hover over or tab to a node or line for details.

Comparability of the trials

Checked across designs (the set of treatments each trial compares) for eligibility, outcome definition and assessment, and the baseline factors above. Flags point to possible intransitivity; notes describe variation that is not tied to design.

No comparability concerns were found.

Comparability items per trial
Trialtime weeksanalysis setdefinitioninstrumentadjudicatedproportion methodintercurrent events (discontinuation)intercurrent events (rescue)blindingfundingstart yearEligibility
NCT0297094272full_analysisChange in SF-36 physical component summary, norm basedSF-36not statednot statednot statednot stateddouble_blindindustry2016age 18 to 75; biopsy NASH F1 to F3; NAS 4 or more; BMI above 25; HbA1c 10 percent or less

Trial data

What each trial contributes. Arm rows give the arm value with its standard error, or events over participants; contrast rows give the mean difference on the analysis scale against the trial's first row. Flags mark converted, combined or approximated inputs.
Trial data entering this analysis
TrialArmTreatmentWeekDataValueSEEvents / NFlagsSource
NCT02970942A1SEMA_SC_0p1MG_QD72arm, change2.1000.78380registry:outcomes
NCT02970942A2SEMA_SC_0p2MG_QD72arm, change1.1000.82778registry:outcomes
NCT02970942A3SEMA_SC_0p4MG_QD72arm, change3.9000.78482registry:outcomes
NCT02970942A4PLACEBO72arm, change-0.1000.92880registry:outcomes

Rerun this analysis yourself

Remove treatments or trials and refit the frequentist and Bayesian models in your browser, with the same methods as the published analysis.

Open in the NMA lab